SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/14/24 Newtyn Management, LLC 13F-HR 12/31/23 2:23K M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size 1: 13F-HR Quarterly Holdings and Combination Report by a HTML 5K Money Manager -- primary_doc.xml/2.2 2: INFO-TABLE Portfolio Securities Holdings Info Table -- HTML 21K infotable.xml
Newtyn Management, LLC
| NY | |
Security | Market Valueª | Shares or Principal | Investment Discretion | Other Managersº | Voting Authority | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Issuer Name | Issue Class | Opt. | CUSIP/CINS | $1000s | Weight | Amount | S/P | Price | Sole | Shared | None | ||
↓List | (S/P Amounts or For All) | ||||||||||||
89BIO INC | COM | – | 282559·10·3 | 3,043,825 | 0.60% | 272,500 | Sh. | 11,170.00 | Sole | – | Sole | – | – |
ADAPTIVE BIOTECHNOLOGIES COR | COM | – | 00650F·10·9 | 1,577,800 | 0.31% | 322,000 | Sh. | 4,900.00 | Sole | – | Sole | – | – |
ADVERUM BIOTECHNOLOGIES INC | COM | – | 00773U·10·8 | 619,627 | 0.12% | 823,096 | Sh. | 752.80 | Sole | – | Sole | – | – |
ALGOMA STL GROUP INC | COM | – | 015658·10·7 | 5,926,717 | 1.18% | 590,899 | Sh. | 10,030.00 | Sole | – | Sole | – | – |
ALIGOS THERAPEUTICS INC | COM | – | 01626L·10·5 | 833,320 | 0.17% | 1,255,000 | Sh. | 664.00 | Sole | – | Sole | – | – |
APARTMENT INVT & MGMT CO | CL A | – | 03748R·74·7 | 13,227,783 | 2.62% | 1,689,372 | Sh. | 7,830.00 | Sole | – | Sole | – | – |
ARCA BIOPHARMA INC | COM | – | 00211Y·50·6 | 457,844 | 0.09% | 269,320 | Sh. | 1,700.00 | Sole | – | Sole | – | – |
ARDAGH METAL PACKAGING S A | SHS | – | L02235·10·6 | 9,465,143 | 1.88% | 2,464,881 | Sh. | 3,840.00 | Sole | – | Sole | – | – |
ARISZ ACQUISITION CORP | RIGHT 99/99/9999 | – | 040450·12·4 | 52,500 | 0.01% | 250,000 | Sh. | 210.00 | Sole | – | Sole | – | – |
ATEA PHARMACEUTICALS INC | COM | – | 04683R·10·6 | 1,550,846 | 0.31% | 508,474 | Sh. | 3,050.00 | Sole | – | Sole | – | – |
AVROBIO INC | COM | – | 05455M·10·0 | 3,718,478 | 0.74% | 2,734,175 | Sh. | 1,360.00 | Sole | – | Sole | – | – |
BLACK DIAMOND THERAPEUTICS I | COM | – | 09203E·10·5 | 786,800 | 0.16% | 280,000 | Sh. | 2,810.00 | Sole | – | Sole | – | – |
BOLT BIOTHERAPEUTICS INC | COM | – | 097702·10·4 | 1,739,959 | 0.35% | 1,553,535 | Sh. | 1,120.00 | Sole | – | Sole | – | – |
BRISTOW GROUP INC | COM | – | 11040G·10·3 | 24,402,438 | 4.84% | 863,192 | Sh. | 28,270.00 | Sole | – | Sole | – | – |
BV FINL INC | COM NEW | – | 05603E·20·8 | 14,180,000 | 2.81% | 1,000,000 | Sh. | 14,180.00 | Sole | – | Sole | – | – |
CANNAE HLDGS INC | COM | – | 13765N·10·7 | 66,922,480 | 13.28% | 3,430,163 | Sh. | 19,510.00 | Sole | – | Sole | – | – |
CITY OFFICE REIT INC | COM | – | 178587·10·1 | 19,571,809 | 3.88% | 3,203,242 | Sh. | 6,110.00 | Sole | – | Sole | – | – |
CYTEIR THERAPEUTICS INC | COM | – | 23284P·10·3 | 9,185,360 | 1.82% | 3,021,500 | Sh. | 3,040.00 | Sole | – | Sole | – | – |
FORUM ENERGY TECHNOLOGIES IN | COM | – | 34984V·20·9 | 4,307,631 | 0.85% | 194,300 | Sh. | 22,170.00 | Sole | – | Sole | – | – |
FORUM ENERGY TECHNOLOGIES IN | NOTE 9.000% 8/0 | – | 34984V·AC·4 | 5,420a | 0.00% | 5,483,872 | Pr. | 98.8% | Sole | – | Sole | – | – |
G III APPAREL GROUP LTD | COM | – | 36237H·10·1 | 25,831,834 | 5.13% | 760,207 | Sh. | 33,980.00 | Sole | – | Sole | – | – |
GALAPAGOS NV | SPON ADR | – | 36315X·10·1 | 8,865,237 | 1.76% | 218,087 | Sh. | 40,650.00 | Sole | – | Sole | – | – |
GARRETT MOTION INC | COM | – | 366505·10·5 | 9,955,487 | 1.98% | 1,029,523 | Sh. | 9,670.00 | Sole | – | Sole | – | – |
HOMOLOGY MEDICINES INC | COM | – | 438083·10·7 | 850,750 | 0.17% | 1,399,260 | Sh. | 608.00 | Sole | – | Sole | – | – |
IAC INC | COM NEW | – | 44891N·20·8 | 63,412,747 | 12.58% | 1,210,629 | Sh. | 52,380.00 | Sole | – | Sole | – | – |
KODIAK SCIENCES INC | COM | – | 50015M·10·9 | 5,384,573 | 1.07% | 1,771,241 | Sh. | 3,040.00 | Sole | – | Sole | – | – |
LEAFLY HOLDINGS INC | W EXP 02/04/202 | – | 52178J·11·3 | 9,964 | 0.00% | 634,640 | Sh. | 15.70 | Sole | – | Sole | – | – |
MBIA INC | COM | – | 55262C·10·0 | 11,475,000 | 2.28% | 1,875,000 | Sh. | 6,120.00 | Sole | – | Sole | – | – |
MERRIMACK PHARMACEUTICALS IN | COM NEW | – | 590328·20·9 | 25,126,237 | 4.99% | 1,873,694 | Sh. | 13,410.00 | Sole | – | Sole | – | – |
MITEK SYS INC | COM NEW | – | 606710·20·0 | 12,942,343 | 2.57% | 992,511 | Sh. | 13,040.00 | Sole | – | Sole | – | – |
MURAL ONCOLOGY PUB LTD CO | ORD SHS | – | G63365·10·3 | 2,634,400 | 0.52% | 445,000 | Sh. | 5,920.00 | Sole | – | Sole | – | – |
NB BANCORP INC | COM | – | 63945M·10·7 | 631,410 | 0.13% | 46,945 | Sh. | 13,449.99 | Sole | – | Sole | – | – |
NI HLDGS INC | COM | – | 65342T·10·6 | 6,895,871 | 1.37% | 530,860 | Sh. | 12,990.00 | Sole | – | Sole | – | – |
NUKKLEUS INC | COM | – | 67054R·10·4 | 76,921 | 0.02% | 26,990 | Sh. | 2,849.98 | Sole | – | Sole | – | – |
OLEMA PHARMACEUTICALS INC | COM | – | 68062P·10·6 | 2,104,500 | 0.42% | 150,000 | Sh. | 14,030.00 | Sole | – | Sole | – | – |
ORTHOFIX MED INC | COM | – | 68752M·10·8 | 14,198,754 | 2.82% | 1,053,320 | Sh. | 13,480.00 | Sole | – | Sole | – | – |
PAR TECHNOLOGY CORP | COM | – | 698884·10·3 | 52,596,320 | 10.44% | 1,208,000 | Sh. | 43,540.00 | Sole | – | Sole | – | – |
PG&E CORP | COM | – | 69331C·10·8 | 4,848,646 | 0.96% | 268,921 | Sh. | 18,030.00 | Sole | – | Sole | – | – |
PHATHOM PHARMACEUTICALS INC | COM | – | 71722W·10·7 | 5,904,919 | 1.17% | 646,760 | Sh. | 9,130.00 | Sole | – | Sole | – | – |
SENSEI BIOTHERAPEUTICS INC | COM | – | 81728A·10·8 | 1,087,840 | 0.22% | 1,572,023 | Sh. | 692.00 | Sole | – | Sole | – | – |
SPECTRUM BRANDS HLDGS INC NE | COM | – | 84790A·10·5 | 19,937,474 | 3.96% | 249,937 | Sh. | 79,770.00 | Sole | – | Sole | – | – |
STAR HLDGS | SHS BEN INT | – | 85512G·10·6 | 6,673,171 | 1.32% | 445,472 | Sh. | 14,980.00 | Sole | – | Sole | – | – |
THERAVANCE BIOPHARMA INC | COM | – | G8807B·10·6 | 21,356,000 | 4.24% | 1,900,000 | Sh. | 11,240.00 | Sole | – | Sole | – | – |
TILLYS INC | CL A | – | 886885·10·2 | 473,391 | 0.09% | 62,784 | Sh. | 7,539.99 | Sole | – | Sole | – | – |
VANDA PHARMACEUTICALS INC | COM | – | 921659·10·8 | 1,223,800 | 0.24% | 290,000 | Sh. | 4,220.00 | Sole | – | Sole | – | – |
VERADIGM INC | COM | – | 01988P·10·8 | 15,333,149 | 3.04% | 1,461,692 | Sh. | 10,490.00 | Sole | – | Sole | – | – |
VIVEON HEALTH ACQUISITION CO | RIGHT 12/31/2025 | – | 92853V·12·2 | 11,250 | 0.00% | 250,000 | Sh. | 45.00 | Sole | – | Sole | – | – |
WAVE LIFE SCIENCES LTD | SHS | – | Y95308·10·5 | 2,575,500 | 0.51% | 510,000 | Sh. | 5,050.00 | Sole | – | Sole | – | – |
— 47 Issuers — | — 48 Issues — | — 48 Holdings: $503,993,267,892ª — | — Sole Manager — | ||||||||||
____________ ª The market value of one Holding (usually Options) was adjusted (a), due to conflicting security prices in other Filings. [ Show Data As Filed ] º Other Included Managers with whom investment discretion is shared as to any Holding: No Other Included Managers |